Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitrion is a prescription multivitamin and mineral supplement developed and marketed by Blue Heron Pharmaceuticals. It is formulated as an oral tablet containing 65 mg of Carbonyl Iron, 1 mg of Folic Acid, 25 mcg of Vitamin B12 (Cyanocobalamin), and 120 mg of Vitamin C (Ascorbic Acid). The product is primarily indicated for the treatment and prevention of iron deficiency anemia and to provide nutritional support for patients with folate deficiency. Carbonyl iron is utilized for its high elemental iron content and favorable safety profile compared to traditional iron salts. The inclusion of Vitamin C facilitates intestinal iron absorption, while Folic Acid and Vitamin B12 are essential co-factors for DNA synthesis and the maturation of erythrocytes during erythropoiesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitrion.